Author Correction: The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems
Crossref DOI link: https://doi.org/10.1038/s41598-021-99380-z
Published Online: 2021-09-28
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kotikalapudi, Nagasuryaprasad
Sampath, Samuel Joshua Pragasam
Sukesh Narayan, Sinha
R., Bhonde
Nemani, Harishankar
Mungamuri, Sathish Kumar
Venkatesan, Vijayalakshmi
Text and Data Mining valid from 2021-09-28
Version of Record valid from 2021-09-28
Article History
First Online: 28 September 2021